AnomIQ is Pivot Path’s AI-powered anomaly detection and compliance management platform designed to proactively identify, investigate, and resolve anomalies across pharmaceutical manufacturing environments, QC laboratories, and enterprise systems. Built for regulated life sciences organizations, AnomIQ helps strengthen data integrity, improve operational visibility, and reduce compliance risks by continuously monitoring critical systems and processes. The platform replaces manual anomaly reviews with structured, rule-based, and audit-ready workflows, enabling organizations to detect and address issues before they impact product quality, compliance, or operational performance.
AnomIQ automates anomaly detection, categorization, risk assessment, investigation management, and compliance tracking across both CDS and non-CDS systems, helping bridge the gap between quality oversight and IT operations. Key capabilities include continuous monitoring and intelligent review, configurable anomaly detection rules and thresholds, risk-based categorization and prioritization, workflow-driven investigation management, advanced traceability and audit trails, and role-based access control. The platform enables users to customize detection parameters according to operational, regulatory, and quality requirements while maintaining complete visibility of every action through inspection-ready records. By centralizing anomaly management and providing real-time insights, AnomIQ helps organizations accelerate investigations, improve decision-making, standardize monitoring practices across sites, and maintain continuous compliance. As part of Pivot Path’s Digital Transformation ecosystem, AnomIQ supports operational excellence by delivering a proactive, data-driven approach to anomaly management and regulatory readiness.
